In glucose-sufficient environments, ACSL4 promotes malignant progression of HCC via stabilization of c-Myc/SREBP1 or enhancement of PAK2 transcription [5, 22], sustaining cell growth via de novo lipogenesis. The gene discussed is SREBF1; the disease is hepatocellular carcinoma.